Target intelligence / Profile preview

Scm polycomb group protein like 4 (SCML4)

Target
SCML4
Molecular classification
Polycomb group protein, Chromatin regulator, Sterile alpha motif (SAM) domain–containing protein, Chromatin-binding protein, Transcriptional regulator
01

Overview

Scm polycomb group protein like 4 (SCML4) is a protein-coding gene that encodes a putative Polycomb group (PcG) protein, primarily acting in the nucleus as a negative regulator of DNA-templated transcription[1][2]. SCML4 proteins function as chromatin regulators, forming multiprotein PcG complexes that maintain the transcriptionally repressive state of homeotic and developmental genes through epigenetic modification and chromatin remodeling[1][2][7]. The gene is predicted to have chromatin binding and histone binding activities, and it is widely classified within the Polycomb and sterile alpha motif (SAM)–containing protein families[4][7]. While its complete functional characterization remains to be clarified, SCML4 is expressed in developmentally relevant tissues and implicated as a candidate gene in coronary artery disease and several congenital disorders based on genetic association studies[2][7]. No current therapeutic drugs or mechanism-of-action data targeting SCML4 have been reported, and it is not a conventional drug target such as a receptor, enzyme, or transporter[2][7]. No specific safety considerations or biomarker roles for SCML4 have been established to date.

Other names
DJ47M23.1sex comb on midleg-like protein 4sex comb on midleg like 4
02

Biological functions

Negative regulation of DNA-templated transcriptionChromatin bindingHistone bindingRegulation of developmental gene expression
03

Disease associations

Candidate association with coronary artery diseaseCleft palateCardiac defectsGenital anomaliesEctrodactylyAdult-onset severe asthma

Beyond the preview

Go deeper on Scm polycomb group protein like 4 (SCML4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scm polycomb group protein like 4 (SCML4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call